Balt
Balt is a French-founded medical device company that designs, manufactures, and sells interventional neuroradiology devices—including embolization coils, flow diverters, and thrombectomy products—for treating ischemic and hemorrhagic strokes and aneurysms, selling to hospitals and ambulatory surgical centers across 70+ countries.
- Company typePrivate
- Founded1977
- HeadquartersMontmorency, France
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Balt does
Balt is a French-headquartered medical device company specializing in interventional neuroradiology (INR) devices used to treat strokes and aneurysms. Founded in 1977, the company pioneered one of the first neurovascular intervention devices and has since built what it describes as the world's broadest portfolio of medical devices for ischemic and hemorrhagic stroke treatment, including embolization coils, flow diverters such as Silk Vista, and thrombectomy devices. Balt has recently extended into the peripheral vascular space with dedicated peripheral embolization products.
The company monetizes through direct hardware sales of medical devices to hospitals and ambulatory surgical centers, delivered through enterprise field sales channels across more than 70 countries. Balt operates from its Paris-area headquarters and from a growing U.S. manufacturing and research footprint in Irvine, California, where it opened an 85,000-square-foot second facility on May 12, 2026 as part of a $400 million multi-year U.S. investment strategy through 2030. Clinical credibility is anchored by publication of the STEM trial results in the New England Journal of Medicine.
Corporate structure comprises Balt SAS as the French parent and Balt USA LLC as the U.S. operating subsidiary, with wholly-owned Blockade Medical contributing neurovascular device IP. Leadership includes Pascal Girin as President and CEO, Léopold Plowiecki as Founder, Dave Ferrera as CTO, and Emeric Domergue as Deputy CFO. The company is privately held with no public listing disclosed.
Balt firmographics
Firmographics- Name
- Balt
- Legal name
- Balt Group
- Website
- https://balt.fr
- Company type
- Private
- Founded year
- 1977
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- Balt is a French-founded medical device company that designs, manufactures, and sells interventional neuroradiology devices—including embolization coils, flow diverters, and thrombectomy products—for treating ischemic and hemorrhagic strokes and aneurysms, selling to hospitals and ambulatory surgical centers across 70+ countries.
- Ownership category
- akta.pro rank
Balt industry classification
Industry- Product category
- Neurovascular Medical Devices
- NAICS
- Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Surgical & Medical Instruments & Apparatus (3841)
- akta.pro primary industry
- Thrombectomy, Embolic Protection & Stroke Intervention Devices (HLAHAFAJ)
Keywords
Where Balt is headquartered
LocationHeadquarters
- HQ city
- Montmorency
- HQ country
- France
- HQ region
- Europe
Offices2 records
Markets served
Balt business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Technology or R&D, Personnel, Marketing or Sales, Infrastructure, Supply Chain
Revenue model
- Medical Device Sales: Sale of neurovascular medical devices including stroke treatment devices and peripheral embolization products to hospitals and healthcare facilities globally
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Balt product offering
Product offeringCore offering
Balt designs, manufactures, and sells neurovascular medical devices used by hospitals and ambulatory surgical centers to treat ischemic and hemorrhagic stroke, cerebral aneurysms, and peripheral embolization conditions. Its portfolio includes embolization coils, occlusion devices, flow diverters such as Silk Vista, and thrombectomy devices, with growing presence in the peripheral vascular space.
Product overview
Balt is a global neurovascular medical device company offering the world's broadest portfolio of medical devices for ischemic and hemorrhagic stroke treatment, as well as dedicated products to address peripheral embolization. Founded in France in 1977, the company operates in more than 70 countries. Balt's product portfolio includes devices like Silk Vista for neurovascular embolization, serving both ischemic and hemorrhagic stroke applications. The company has recently expanded into the peripheral vascular space while maintaining its leadership in stroke treatment technologies.
Differentiator
Problem solved
Functional benefit
Products and services
- Silk Vista Neurovascular embolization device used by hospitals and interventional neuroradiologists for the treatment of ischemic and hemorrhagic stroke, part of Balt's broad portfolio of minimally invasive neurovascular medical devices.
- Neurovascular Embolization Coils and Occlusion Devices Coil transcatheter embolization and occlusion devices used by hospitals for the minimally invasive treatment of neurovascular conditions including stroke and cerebral aneurysms.
- Peripheral Embolization Products
Quantifiable outcome
- STEM trial results published in New England Journal of Medicine
Companies that use Balt
Customer profileNamed customers2 records
Segments2 records
Ideal customer profiles1 record
Balt technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Balt partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Blockade MedicalacquisitionBalt acquired Blockade Medical, a neurovascular and stroke treatment device company founded by David Ferrera. This acquisition strengthened Balt's portfolio of neurovascular devices for stroke treatment.
Scale indicators4 records
Recent moves7 records
Expansion highlights6 records
Balt competitors and assessment
Company assessmentDirect peers
- Stryker (Neurovascular): Stryker's Neurovascular division (acquired via the $1.4B acquisition of Concentric Medical, Sage, and Penumbra-adjacent assets) is one of the largest direct competitors in stroke intervention devices. Overlapping product lines include stent retrievers, aspiration catheters, and flow diverters sold into the same hospital neurointerventional suites.
- Medtronic (Neurovascular): Medtronic's Neurovascular operating unit competes head-to-head with Balt in coils, flow diverters (Pipeline), and stent retrievers. As a global medtech incumbent, Medtronic competes with Balt's Silk Vista and broader portfolio in the same hospital channels.
- Penumbra Inc. Penumbra is a U.S.-based direct competitor specializing in aspiration thrombectomy systems for stroke (Penumbra System, RED catheters) and peripheral vascular. Penumbra competes with Balt in both ischemic stroke and peripheral embolization markets.
- Cerenovus (Johnson & Johnson): Cerenovus, J&J's neurovascular business, offers coils, flow diverters, and stroke intervention devices. As a deep-pocketed incumbent, Cerenovus competes with Balt across its full neurovascular portfolio in U.S. and global hospital channels.
- MicroPort Scientific (Neurovascular): MicroPort acquired Rapid Medical and operates a neurovascular portfolio competing with Balt in flow diverters and stroke devices. MicroPort's broader geographic footprint in EMEA and APAC overlaps with Balt's 70+ country presence.
- Rapid Medical: Rapid Medical develops adjustable neurovascular devices (stent retrievers, flow diverters). Acquired by MicroPort, Rapid Medical competes directly with Balt in the same clinical use cases for stroke and aneurysm treatment.
- Phenox GmbH: Phenox is a European-headquartered neurovascular device company with flow diverters (p64, p48MW), coils, and stent retrievers. Comparable in scale and product breadth to Balt's neurovascular portfolio, primarily serving EMEA and select global markets.
Broad incumbents
- Terumo (Neurovascular): Terumo is a global medical device conglomerate with neurovascular products through its Terumo Neuro division (acquired from MicroVention). Competes with Balt across coils, flow diverters, and access devices as part of a much broader medical device portfolio.
Emerging players
- Inari Medical: Inari Medical specializes in venous thromboembolism and peripheral vascular intervention devices. As Balt expands into peripheral embolization, Inari represents an emerging competitor in the adjacent peripheral vascular space.
- InspireMD: InspireMD develops neurovascular and carotid artery stents (CGuard). An emerging player with partial product overlap with Balt's neurovascular portfolio, focused on stroke prevention rather than acute intervention.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Balt social profiles
Digital presenceBalt compliance and trust
Trust signalCompliance1 record
Balt financial estimates
Financial estimateRevenue estimate
Valuation estimate
Balt leadership team
Management profileNumber of profiles
Profiles4 records
Balt subsidiaries and ownership
Company hierarchySubsidiaries2 records
Balt funding detail
Funding detailFunding overview
Funding rounds2 records
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Balt M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Balt
What does Balt do?
Balt designs, manufactures, and sells neurovascular medical devices used by hospitals and ambulatory surgical centers to treat ischemic and hemorrhagic stroke, cerebral aneurysms, and peripheral embolization conditions. Its portfolio includes embolization coils, occlusion devices, flow diverters such as Silk Vista, and thrombectomy devices, with growing presence in the peripheral vascular space.
Is Balt a public or private company?
Balt is a private company. It is classified as venture growth investor backed and is currently operating.
When was Balt founded?
Balt was founded in 1977. It employs 501 to 1,000 people.
Where is Balt based?
Balt is headquartered in Montmorency, France, in the Europe region.
How does Balt make money?
One revenue line is on record: medical Device Sales.
Who are Balt's main competitors?
Direct peers on record are Stryker (Neurovascular), Medtronic (Neurovascular), Penumbra Inc., Cerenovus (Johnson & Johnson), MicroPort Scientific (Neurovascular), Rapid Medical and Phenox GmbH. Terumo (Neurovascular) is listed as a broad incumbent. Emerging players are Inari Medical and InspireMD.
Does Balt have an API?
No public API is recorded for Balt.
What industry is Balt in?
Balt's product category is Neurovascular Medical Devices. Its primary akta.pro industry code is HLAHAFAJ, Thrombectomy, Embolic Protection & Stroke Intervention Devices. Its NAICS code is 339112 and its SIC code is 3841.